79 related articles for article (PubMed ID: 3820734)
61. Enhancement of tumor growth in natural killer cell-deficient mice by allogeneic transfusion.
Francis DM; Purcell L
Am J Surg; 1991 Apr; 161(4):411-2. PubMed ID: 2035757
[No Abstract] [Full Text] [Related]
62. Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice.
Cui Z; Willingham MC; Hicks AM; Alexander-Miller MA; Howard TD; Hawkins GA; Miller MS; Weir HM; Du W; DeLong CJ
Proc Natl Acad Sci U S A; 2003 May; 100(11):6682-7. PubMed ID: 12724523
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of natural killer cell activity in vitro by alcohols.
Ristow SS; Starkey JR; Hass GM
Biochem Biophys Res Commun; 1982 Apr; 105(4):1315-21. PubMed ID: 7103955
[No Abstract] [Full Text] [Related]
64. Natural killers to rescue immune surveillance?
Bloom BR
Nature; 1982 Nov; 300(5889):214-5. PubMed ID: 7144879
[No Abstract] [Full Text] [Related]
65. The Nature of the Reaction of the Tissues of susceptible and non-susceptible Mice to an inoculable Tumor.
Burgess AM
J Med Res; 1909 Oct; 21(3):575-590.5. PubMed ID: 19971931
[No Abstract] [Full Text] [Related]
66. Detection of allogeneic Qa/TL and Ly specificities on murine tumor cells with IgD in tumor-regressor serum.
Tanino T; Seo N; Okazaki T; Nakanishi-Ito C; Sekimata M; Egawa K
Cancer Immunol Immunother; 1992; 35(4):230-6. PubMed ID: 1380893
[TBL] [Abstract][Full Text] [Related]
67. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
Teh HS; Yu M
J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
[TBL] [Abstract][Full Text] [Related]
68. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
Paul RD; Padmanabhan R; Lopez DM
Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
[TBL] [Abstract][Full Text] [Related]
69. T cell-dependent nonspecific cytotoxicity induced by culture of mouse spleen cells against natural killer-insensitive tumor cells.
Kiyohara T; Tanino T; Egawa K
Jpn J Exp Med; 1982 Aug; 52(4):201-8. PubMed ID: 7176145
[TBL] [Abstract][Full Text] [Related]
70. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
71. Non-H-2 restriction specificity of tumor-regressor mouse sera with regard to their activity to inhibit tumor cell transplantation.
Egawa K; Kiyohara T; Tanino T
Jpn J Exp Med; 1982 Oct; 52(5):255-60. PubMed ID: 7169670
[TBL] [Abstract][Full Text] [Related]
72. Regressor serum factor-dependent nonspecific killers in tumor-bearing mice.
Tanino T; Egawa K
Jpn J Exp Med; 1986 Aug; 56(4):163-8. PubMed ID: 3820734
[TBL] [Abstract][Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
